Skip to main content

Medtronic plc. (MDT) Stock Analysis

Falling Knife setup

SellModerate Confidence

Healthcare · Medical Devices

Sell if holding. Momentum 1.2/10 is below the 5.0 floor at $79.47 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Weak growth.

Medtronic plc is a global medical device company with four segments—Cardiovascular, Neuroscience, Medical Surgical, and Diabetes—serving healthcare systems in 150+ countries. It develops, manufactures, and sells implantable devices, surgical tools, and monitoring systems;... Read more

$79.47+22.5% A.UpsideScore 5.2/10#29 of 40 Medical Devices
Stop $76.54Target $97.20(analyst − 10%)A.R:R 4.5:1
Analyst target$108.00+35.9%25 analysts
$97.20our TP
$79.47price
$108.00mean
$121

Sell if holding. Momentum 1.2/10 is below the 5.0 floor at $79.47 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Weak growth. Chart setup: Death cross, below all MAs, RSI 23, MACD bearish. Score 5.2/10, moderate confidence.

Passes 5/6 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, earnings proximity 34d clear, semi cycle peak clear). Fails on weak momentum. Suitability: moderate.

Thesis

Rewards
Strong earnings beat streak (4/4)
Analyst upside: 22%
Risks
Weak growth
Negative momentum

Key Metrics

P/E (TTM)22.2
P/E (Fwd)13.1
Mkt Cap$101.9B
EV/EBITDA12.9
Profit Mgn13.0%
ROE9.4%
Rev Growth8.7%
Beta0.76
Dividend3.58%
Rating analysts37

Quality Signals

Piotroski F8/9

Options Flow

P/C1.72bearish
IV38%normal
Max Pain$74-6.9% vs spot

Concentration Risks(10-K Item 1A)

  • MEDIUMSuppliersole suppliers
    10-K Item 1A: 'certain components, raw materials and services needed to manufacture our products are obtained from sole suppliers'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd
0.0
Volume
0.0
Obv
1.0
Ma Position
2.2
Rsi
3.0
Capitulation risk (RSI 23, below 200MA)Volume distribution (falling OBV)Below 200-MA but MA still rising (+0.0%/30d) — pullback in uptrend, not confirmed weakness

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Earnings Growth
0.0
Revenue Growth
4.7
GatesMomentum 1.2<4.5A.R:R 4.5 ≥ 1.5Insider activity: OKNo SEC red flagsEARNINGS PROXIMITY 34d clearSEMI CYCLE PEAK CLEARFalling KnifeSuitability: Moderate
RSI
23 · Oversold
20D MA 50D MA 200D MADEATH CROSSSupport $78.91Resistance $88.84

Price Targets

$77
$97
A.Upside+22.3%
A.R:R4.5:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Momentum score 1.2/10 — below 4.5 minimum

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-06-03 (34d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is MDT stock a buy right now?

Sell if holding. Momentum 1.2/10 is below the 5.0 floor at $79.47 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Weak growth. Chart setup: Death cross, below all MAs, RSI 23, MACD bearish. Prior stop was $76.54. Score 5.2/10, moderate confidence.

What is the MDT stock price target?

Take-profit target: $97.20 (+22.5% upside). Prior stop was $76.54. Stop-loss: $76.54.

What are the risks of investing in MDT?

Weak growth; Negative momentum.

Is MDT overvalued or undervalued?

Medtronic plc. trades at a P/E of 22.2 (forward 13.1). TrendMatrix value score: 6.7/10. Verdict: Sell.

What do analysts say about MDT?

37 analysts cover MDT with a consensus score of 3.8/5. Average price target: $108.

What does Medtronic plc. do?Medtronic plc is a global medical device company with four segments—Cardiovascular, Neuroscience, Medical Surgical, and...

Medtronic plc is a global medical device company with four segments—Cardiovascular, Neuroscience, Medical Surgical, and Diabetes—serving healthcare systems in 150+ countries. It develops, manufactures, and sells implantable devices, surgical tools, and monitoring systems; revenue comes from hospital and physician purchases of capital equipment and related disposables. The company has announced plans to separate its Diabetes segment.

Related stocks: BSX (Boston Scientific Corporation) · GMED (Globus Medical, Inc.) · DXCM (DexCom, Inc.) · PEN (Penumbra, Inc.) · PODD (Insulet Corporation)